However, we cannot exclude that salinomycin may stimulate the sensitivity of glioblastoma stem cells to TRAIL, acting through molecular mechanisms differrent from TRAIL-R2 upmodulation. The gene discussed is TNFRSF10B; the disease is glioblastoma.